Ascletis Pharma (@ascletisp) 's Twitter Profile
Ascletis Pharma

@ascletisp

ID: 1589465332758052864

calendar_today07-11-2022 03:51:52

124 Tweet

14 Followers

0 Following

Ascletis Pharma (@ascletisp) 's Twitter Profile Photo
Ascletis Pharma
@ascletisp

3 months ago

Ascletis Announces First Participants Dosed in U.S. Phase I Clinical Study of ASC50, a Potential Best-in-Class Oral Small Molecule IL-17 Inhibitor for the Treatment of Psoriasis ascletis.com/news_detail/19…